Access to the PPM Journal and newsletters is FREE for clinicians.
12 Articles in this Series
Central Post-Stroke Pain – How Central Is It?
False-Positive Urine Drug Monitoring Results and Aspirin
Medical Marijuana & Pain
More Potential Uses for Low-Dose IV Naloxone
On the Horizon: A Brief Look at Potential Analgesics of the Future
Preview of PAINWeek 2018 - Know Before You Go
Stem Cells & Beyond
Underlying Causes of Small Fiber Neuropathies
Understanding Sexual Pain – A Physical Therapist’s Perspective
Video: Drs. Gudin & Fudin on PAINWeek 2018 and PPM's Future
Where Does the Patient-Centered Pain Practitioner Stand Today?
Why Interventional Tactics Should be Used for Chronic Pain Patients Now, Not Later

Preview of PAINWeek 2018 - Know Before You Go

With Debra Weiner, PAINWeek's Executive Vice President for Program Development

In what exciting ways do you see pain assessment and management changing over the next 5 to 10 years?

Assessment practices are likely to change in terms of finding more ways to examine functional impact as opposed to just a subjective pain rating. Look for the contextual narrative that the chronic patient brings with them to become much more important, for example.

Regarding chronic pain management, gaps will need to be filled by the movement in today’s environment away from utilizing opioid analgesics in high doses on a long-term basis; this is essential in order to make sure chronic pain patients still get the care they need and deserve. Saying “no” to one treatment means that you have to say “yes” to something else. In the next decade, we will need to identify what the replacement treatment plans consist of.

How can healthcare providers better work together to improve pain care? What skills or knowledge might they gain from PAINWeek in this regard?

One of the more subtle benefits of attending PAINWeek is the high level of communication between the faculty and attendees, and between attendees with each other. As our healthcare system continues to evolve—and despite best efforts—communication between healthcare providers seems to be decreasing instead of increasing – that needs to change. One simple thing that healthcare providers can do to improve pain care is to increase the level of communication with each other, and with their patients. This will be reinforced in many of the sessions this year in many different ways.

What’s new at PAINWeek 2018 that has not been offered in past years?

PAINWeek sets itself apart by providing 120-plus CE/CME hours over the five-day conference. Highlights of this year’s curriculum include timely and relevant workshops on:

  • Cannabis and Cannabinoids, with Douglas L. Gourlay, MD, MSc, FRCPC, FASAM; Mary Lynn McPherson, PharmD, MA, BCPS, CPE
  • Patient-Centered Opioid Reduction, with Beth Darnall, PhD; Ming-Chih Kao, MD; and Sean C. Mackey, MD, PhD
  • Palliative Care Bootcamp, with  Frank D. Ferris, MD; Jessica Geiger-Hayes, PharmD, BCPS, CPE; Mary Lynn McPherson, PharmD, MA, BCPS, CPE;  Alexandra McPherson, PharmD, MPH.

There are more than 12 tracks that attendees can pursue, including: acute, behavioral, interventional, and integrative pain management, or chronic pain syndromes. The American Headache Society, the American Pain Society, and the International, and International Pelvic Pain Society will present full-day programs, and master classes will cover special interest areas ranging from Brain-Based Biomarkers for Pain and Involuntary Tapers, to IV Naloxone Infusion and Neurogenic Thoracic Outlet Syndrome.

Overall, participants should be to be able to take away current, clinically practical, and relevant knowledge that can be meaningfully implemented into practice to help better manage patients with chronic pain as safely and effectively as possible. Plus, the variety of abstracts always make PAINWeek very attractive – guaranteed, there will be something for everyone.


Be sure to stop by PPM's Booth #430 to chat with new Co-Editors-at-Large Jeff Gudin, MD, and Jeffrey Fudin, PharmD. Follow meeting coverage on Twitter@PracticalPain.

Next summary: Stem Cells & Beyond
close X